Dual loss of the SWI / SNF complex ATPases SMARCA4 / BRG1 and SMARCA2 / BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type-Reference-Cited by-同舟云学术

Dual loss of the SWI / SNF complex ATPases SMARCA4 / BRG1 and SMARCA2 / BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

Published:2015-12-21 Issue:3 Volume:238 Page:389-400
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Karnezis Anthony N¹,Wang Yemin¹,Ramos Pilar²,Hendricks William PD²,Oliva Esther³,D'Angelo Emanuela⁴,Prat Jaime⁴,Nucci Marisa R⁵,Nielsen Torsten O¹,Chow Christine⁶,Leung Samuel⁶,Kommoss Friedrich⁷,Kommoss Stefan⁸,Silva Annacarolina⁹,Ronnett Brigitte M¹⁰,Rabban Joseph T¹¹,Bowtell David D¹²,Weissman Bernard E¹³,Trent Jeffrey M²,Gilks C Blake¹,Huntsman David G¹⁶¹⁴

Affiliation:

1. Department of Pathology and Laboratory Medicine University of British Columbia Vancouver BC Canada

2. Division of Integrated Cancer Genomics Translational Genomics Research Institute (TGen) Phoenix AZ USA

3. Department of Pathology Massachusetts General Hospital Boston MA USA

4. Department of Pathology, Hospital de la Santa Creu i Sant Pau Autonomous University of Barcelona Barcelona Spain

5. Department of Pathology Brigham and Women's Hospital Boston MA USA

6. Genetic Pathology Evaluation Centre, Vancouver General Hospital University of British Columbia Vancouver BC Canada

7. Synlab MVZ Pathologie Mannheim Germany

8. Department of Obstetrics and Gynecology University Hospital of Tuebingen Tuebingen Germany

9. The James Homer Wright Pathology Laboratories Massachusetts General Hospital, Harvard Medical School Boston MA USA

10. Department of Pathology The Johns Hopkins Hospital Baltimore MD USA

11. Department of Anatomic Pathology University of California San Francisco San Francisco CA USA

12. Peter MacCallum Cancer Centre East Melbourne Victoria Australia

13. Department of Pathology and Laboratory Medicine, Lineberger Cancer Center University of North Carolina Chapel Hill NC USA

14. Department of Molecular Oncology British Columbia Cancer Research Centre Vancouver BC Canada

Funder

National Institutes of Health

Marsha Rivkin Center for Ovarian Cancer Research

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.4633

Reference44 articles.

1. Small Cell Carcinoma of the Ovary, Hypercalcemic Type

2. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4

3. Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

4. Ovarian small cell carcinoma of hypercalcemic type – evidence of germline origin and smarca4 gene inactivation. a pilot study

5. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SWI/SNF Complex-Deficient Undifferentiated Carcinoma of the Pancreas: Clinicopathologic and Genomic Analysis;Modern Pathology;2024-11

2. Aberrant SWI/SNF Complex Members Are Predominant in Rare Ovarian Malignancies—Therapeutic Vulnerabilities in Treatment-Resistant Subtypes;Cancers;2024-09-03

3. MR imaging diagnosis of small-cell carcinoma of the ovary, hypercalcemic type: A case report and literature review;Medicine;2024-08-09

4. SMARCA4-Deficient Undifferentiated Esophageal Carcinoma: A Clinical Case Series and Literature Review;Journal of Gastrointestinal Cancer;2024-04-24

5. SMARCA4-Deficient Undifferentiated Esophageal Carcinoma: A Clinical Case Series and Literature Review;2024-02-12